Nathan Hardy

Insider Reports History

Entity
Individual
Location
C/O Sana Biotechnology, Inc., 188 East Blaine Street, Suite 400, Seattle, WA
Signature
/s/ Julie Shah, Attorney-in-Fact for Nathan Hardy
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathan Hardy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. EVP, Chief Financial Officer Restricted Stock Units 67.1K $369K $5.50 Mar 7, 2024 Direct
Sana Biotechnology, Inc. EVP, Chief Financial Officer Stock Option (Right to Buy) 302K Mar 7, 2024 Direct

Insider Reports Filed by Nathan Hardy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SANA Sana Biotechnology, Inc. Mar 7, 2024 2 $0 4 Mar 8, 2024 EVP, Chief Financial Officer
SANA Sana Biotechnology, Inc. Nov 2, 2023 1 $0 4 Nov 3, 2023 EVP, Chief Financial Officer
SANA Sana Biotechnology, Inc. Mar 2, 2023 1 $0 4 Mar 3, 2023 EVP, Chief Financial Officer
SANA Sana Biotechnology, Inc. Mar 3, 2022 1 $0 4 Mar 8, 2022 EVP, Chief Financial Officer